<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04087122</url>
  </required_header>
  <id_info>
    <org_study_id>WMC-Cryo</org_study_id>
    <nct_id>NCT04087122</nct_id>
  </id_info>
  <brief_title>Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures</brief_title>
  <official_title>Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Advanced Cooling Therapy, Inc., d/b/a Attune Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Winchester Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Advanced Cooling Therapy, Inc., d/b/a Attune Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Left atrial catheter ablation including pulmonary vein isolation is a standard therapy in the&#xD;
      management of symptomatic atrial fibrillation; however thermal esophageal injury is a known&#xD;
      potential consequence of this procedure. Delivery of radiofrequency (RF) energy necessary to&#xD;
      perform left atrial ablation has the potential to cause injury to the nearby esophagus&#xD;
      including ulceration, hematoma, spasm, esophageal motility disorders, and, in the most&#xD;
      extreme case, atrial-esophageal fistula.Esophageal mucosal lesions are the likely precursor&#xD;
      to AEF, and esophageal mucosal lesions have been detected on post-ablation endoscopy after&#xD;
      pulmonary vein isolation with an incidence ranging from 3% to 60%.&#xD;
&#xD;
      Active esophageal cooling during RF ablation as a means of esophageal injury prevention has&#xD;
      been investigated through mathematical models, pre-clinical studies, and in clinical trials.&#xD;
      Existing data support the efficacy of this approach, but the practice has not been widely&#xD;
      adopted due to lack of a commercially available device.&#xD;
&#xD;
      The aim of this study is to evaluate the impact on procedural efficiency of ablation&#xD;
      procedures performed using esophageal heat transfer to warm the esophagus during left atrial&#xD;
      cryoablation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective, pilot study using the Attune Medical ensoETM esophageal heat&#xD;
      transfer device to actively warm the esophagus during cryoablation procedures. This design is&#xD;
      appropriate to gather the data needed regarding overall procedural time, compare this to&#xD;
      historical controls, and estimate a sample size for a larger study powered for statistical&#xD;
      significance.&#xD;
&#xD;
      Once patient consent is obtained, the subject will undergo preparation and anesthesia&#xD;
      procedures following standard practice. Once the patient is intubated, the esophageal heat&#xD;
      transfer device will be placed into the esophagus according to the IFU. The device will&#xD;
      remain in place until the ablation procedure is completed and will be removed before&#xD;
      extubation. Left atrial cryoablation using the standard approach will be performed with the&#xD;
      ensoETM set at a temperature of 42 degrees C.&#xD;
&#xD;
      All patients will be followed up in total for 6 weeks (Long Term FU visit) after the&#xD;
      procedure to document any clinical complication related to thermal esophageal injuries if&#xD;
      applicable.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 30, 2019</start_date>
  <completion_date type="Actual">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">July 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Time of Active Ablation Procedure</measure>
    <time_frame>Study Day 1 for all patients enrolled, during left atrial ablation procedures using cryoablation</time_frame>
    <description>Total time of active ablation procedure measured from trans-septal puncture to achievement of Pulmonary Vein Isolation (PVI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Procedure Time</measure>
    <time_frame>Study Day 1 for all patients enrolled from patient entry to Electrophysiology (EP) lab until post procedure discharge to Post-Anesthesia Care Unit (PACU)]</time_frame>
    <description>Total procedure time from patient entry to Electrophysiology (EP) lab until discharge to Post-Anesthesia Care Unit (PACU)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Procedural Pauses During Left Atrial Instrumentation</measure>
    <time_frame>Study Day 1 for all patients, during left atrial ablation procedures using cryoablation</time_frame>
    <description>Number of procedural pauses during left atrial instrumentation measured from trans-septal puncture to achievement of Pulmonary Vein Isolation (PVI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Duration of Fluoroscopy Use</measure>
    <time_frame>Study Day 1 for all patients, during left atrial ablation procedures using cryoablation</time_frame>
    <description>Total duration of fluoroscopy use during left atrial instrumentation measured from trans-septal puncture to achievement of Pulmonary Vein Isolation (PVI)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Esophageal warming</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive the Attune Medical Esophageal Heat Transfer Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Esophageal warming device (Attune Medical, Chicago, IL</intervention_name>
    <description>Prospective, single center pilot stud</description>
    <arm_group_label>Esophageal warming</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (age over 18 years).&#xD;
&#xD;
          -  Undergoing cryoablation for the treatment of atrial fibrillation, including pulmonary&#xD;
             vein isolation.&#xD;
&#xD;
          -  Patients must be able to understand and critically review the informed consent form.&#xD;
&#xD;
          -  Subjects must understand and agree to study requirements and sign a written informed&#xD;
             consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who are unable to provide informed consent.&#xD;
&#xD;
          -  Significant co-morbidities that preclude standard ablation procedure.&#xD;
&#xD;
          -  Patients with &lt;40 kg of body mass.&#xD;
&#xD;
          -  Patients with relevant esophageal pathology (e.g. esophageal cancer).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Alexander, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Winchester Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zachary Hollis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Winchester Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Winchester Medical Center</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>September 10, 2019</study_first_submitted>
  <study_first_submitted_qc>September 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 12, 2019</study_first_posted>
  <results_first_submitted>August 10, 2021</results_first_submitted>
  <results_first_submitted_qc>August 10, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 5, 2021</results_first_posted>
  <last_update_submitted>August 10, 2021</last_update_submitted>
  <last_update_submitted_qc>August 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 12, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/22/NCT04087122/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Esophageal Warming</title>
          <description>Patients receive the Attune Medical Esophageal Heat Transfer Device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Esophageal Warming</title>
          <description>Patients receive the Attune Medical Esophageal Heat Transfer Device</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.5" spread="8.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Time of Active Ablation Procedure</title>
        <description>Total time of active ablation procedure measured from trans-septal puncture to achievement of Pulmonary Vein Isolation (PVI)</description>
        <time_frame>Study Day 1 for all patients enrolled, during left atrial ablation procedures using cryoablation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Esophageal Warming</title>
            <description>Patients receiving the Attune Medical Esophageal Heat Transfer Device</description>
          </group>
        </group_list>
        <measure>
          <title>Total Time of Active Ablation Procedure</title>
          <description>Total time of active ablation procedure measured from trans-septal puncture to achievement of Pulmonary Vein Isolation (PVI)</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126" lower_limit="112" upper_limit="139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Procedure Time</title>
        <description>Total procedure time from patient entry to Electrophysiology (EP) lab until discharge to Post-Anesthesia Care Unit (PACU)</description>
        <time_frame>Study Day 1 for all patients enrolled from patient entry to Electrophysiology (EP) lab until post procedure discharge to Post-Anesthesia Care Unit (PACU)]</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Procedural Pauses During Left Atrial Instrumentation</title>
        <description>Number of procedural pauses during left atrial instrumentation measured from trans-septal puncture to achievement of Pulmonary Vein Isolation (PVI)</description>
        <time_frame>Study Day 1 for all patients, during left atrial ablation procedures using cryoablation</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Duration of Fluoroscopy Use</title>
        <description>Total duration of fluoroscopy use during left atrial instrumentation measured from trans-septal puncture to achievement of Pulmonary Vein Isolation (PVI)</description>
        <time_frame>Study Day 1 for all patients, during left atrial ablation procedures using cryoablation</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>145 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Esophageal Warming</title>
          <description>Patients receive the Attune Medical Esophageal Heat Transfer Device</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Rebekah Smith, RN, BSN</name_or_title>
      <organization>Valley Health</organization>
      <phone>540-536-5547</phone>
      <email>rsmith3@valleyhealthlink.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

